Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women

Psychoneuroendocrinology

Volumn 37, Issue 6, 2012, Pages 773-781

  van Rooij, Kim ^a,b   Bloemers, Jos ^a,b   de Leede, Leo ^c   Goldstein, Irwin ^d   Lentjes, Eef ^e   Koppeschaar, Hans ^a   Olivier, Berend ^b,f   Tuiten, Adriaan ^a,e  

^a Emotional Brain BV   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Exelion Bio Pharmaceutical Consultancy BV   (Netherlands)

^d San Diego Sexual Medicine   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pharmacokinetics; SHBG; Sublingual testosterone

Indexed keywords

ANDROSTANOLONE; PLACEBO; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TESTOSTERONE BLOOD LEVEL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, SUBLINGUAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-OVER STUDIES; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; MASS SPECTROMETRY; PREMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 84859832013     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.09.008     Document Type: Article

References (36)

1. Aleman A., Bronk E., Kessels R.P., Koppeschaar H.P., van Honk J. A single administration of testosterone improves visuospatial ability in young women. Psychoneuroendocrinology 2004, 29:612-617.
2. Auger A.P. Steroid receptor control of reproductive behavior. Horm. Behav. 2004, 45:168-172.
3. Bancroft J., Sherwin B.B., Alexander G.M., Davidson D.W., Walker A. Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens. Arch. Sex Behav. 1991, 20:121-135.
4. Bos P.A., Terburg D., van Honk J. Testosterone decreases trust in socially naive humans. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9991-9995.
5. Bos P.A., Panksepp J., Bluthe R.M., Honk J.V. Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: A review of single administration studies. Front. Neuroendocrinol. 2011, 10.1016/j.yfrne.2011.01.002.
6. Braunstein G.D., Reitz R.E., Buch A., Schnell D., Caulfield M.P. Testosterone reference ranges in normally cycling healthy premenopausal women. J. Sex Med. 2011, 10.1111/j.1743-6109.2011.02380.x.
7. Brewster M.E., Estes K.S., Loftsson T., Perchalski R., Derendorf H., Mullersman G., Bodor N. Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. J. Pharm. Sci. 1988, 77:981-985.
8. Davison S., Thipphawong J., Blanchard J., Liu K., Morishige R., Gonda I., Okikawa J., Adams J., Evans A., Otulana B., Davis S. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. J. Clin. Pharmacol. 2005, 45:177-184.
9. Eisenegger C., Haushofer J., Fehr E. The role of testosterone in social interaction. Trends Cogn. Sci. 2011, 15:263-271.
10. Eisenegger C., Naef M., Snozzi R., Heinrichs M., Fehr E. Prejudice and truth about the effect of testosterone on human bargaining behaviour. Nature 2010, 463:356-359.
11. Hermans E.J., Putman P., van Honk J. Testosterone administration reduces empathetic behavior: a facial mimicry study. Psychoneuroendocrinology 2006, 31:859-866.
12. Hermans E.J., Ramsey N.F., van Honk J. Exogenous testosterone enhances responsiveness to social threat in the neural circuitry of social aggression in humans. Biol. Psychiatry 2008, 63:263-270.
13. Hermans E.J., Putman P., Baas J.M., Gecks N.M., Kenemans J.L., van Honk J. Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology 2007, 32:1052-1061.
14. Hull E.M., Dominguez J.M. Sexual behavior in male rodents. Horm. Behav. 2007, 52:45-55.
15. Judd H.L., Yen S.S.C. Serum androstenedione and testosterone levels during menstrual-cycle. J. Clin. Endocrinol. Metab. 1973, 36:475-481.
16. Labrie F., Belanger A., Belanger P., Berube R., Martel C., Cusan L., Gomez J., Candas B., Castiel I., Chaussade V., Deloche C., Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J. Steroid Biochem. Mol. Biol. 2006, 99:182-188.
17. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 1989, 10:232-274.
18. Miller K.K., Rosner W., Lee H., Hier J., Sesmilo G., Schoenfeld D., Neubauer G., Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin. Endocrinol. Metab. 2004, 89:525-533.
19. Mulders T.M.T., Dieben T.O.M. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil. Steril. 2001, 75:865-870.
20. Postma A., Meyer G., Tuiten A., van Honk J., Kessels R.P., Thijssen J. Effects of testosterone administration on selective aspects of object-location memory in healthy young women. Psychoneuroendocrinology 2000, 25:563-575.
21. Rothman M.S., Carlson N.E., Xu M., Wang C., Swerdloff R., Lee P., Goh V.H., Ridgway E.C., Wierman M.E. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 2011, 76:177-182.
22. Salehian B., Wang C., Alexander G., Davidson T., McDonald V., Berman N., Dudley R.E., Ziel F., Swerdloff R.S. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate: a clinical research center study. J. Clin. Endocrinol. Metab. 1995, 80:3567-3575.
23. Salonia A., Pontillo M., Nappi R.E., Zanni G., Fabbri F., Scavini M., Daverio R., Gallina A., Rigatti P., Bosi E., Bonini P.A., Montorsi F. Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J. Sex Med. 2008, 5:854-863.
24. Schutter D.J., van Honk J. Decoupling of midfrontal delta-beta oscillations after testosterone administration. Int. J. Psychophysiol. 2004, 53:71-73.
25. Sherwin B.B. Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning. Fertil. Steril. 2002, 77:S49-S54.
26. Shifren J.L., Braunstein G.D., Simon J.A., Casson P.R., Buster J.E., Redmond G.P., Burki R.E., Ginsburg E.S., Rosen R.C., Leiblum S.R., Caramelli K.E., Mazer N.A., Jones K.P., Daugherty C.A. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. 2000, 343:682-688.
27. Simon J., Braunstein G., Nachtigall L., Utian W., Katz M., Miller S., Waldbaum A., Bouchard C., Derzko C., Buch A., Rodenberg C., Lucas J., Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. 2005, 90:5226-5233.
28. Stuenkel C.A., Dudley R.E., Yen S.S. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men. J. Clin. Endocrinol. Metab. 1991, 72:1054-1059.
29. Tuiten A., Van Honk J., Koppeschaar H., Bernaards C., Thijssen J., Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch. Gen. Psychiatry 2000, 57:149-153. discussion 155-156.
30. Tuiten A., van Honk J., Verbaten R., Laan E., Everaerd W., Stam H. Can sublingual testosterone increase subjective and physiological measures of laboratory-induced sexual arousal?. Arch. Gen. Psychiatry 2002, 59:465-466.
31. van der Made F., Bloemers J., Yassem W.E., Kleiverda G., Everaerd W., van Ham D., Olivier B., Koppeschaar H., Tuiten A. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. J. Sex Med. 2009, 6:777-790.
32. van Honk J., Schutter D.J. Testosterone reduces conscious detection of signals serving social correction: implications for antisocial behavior. Psychol. Sci. 2007, 18:663-667.
33. van Honk J., Peper J.S., Schutter D.J. Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol. Psychiatry 2005, 58:218-225.
34. van Honk J., Schutter D.J., Hermans E.J., Putman P., Tuiten A., Koppeschaar H. Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women. Psychoneuroendocrinology 2004, 29:937-943.
35. van Honk J., Tuiten A., Hermans E., Putman P., Koppeschaar H., Thijssen J., Verbaten R., van Doornen L. A single administration of testosterone induces cardiac accelerative responses to angry faces in healthy young women. Behav. Neurosci. 2001, 115:238-242.
36. Zhang H., Zhang J., Streisand J.B. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 2002, 41:661-680.